ormant pulmonary vein (PV) conduction can be revealed by the administration of adenosine triphosphate (ATP) just after PV isolation (PVI). 1 Recent studies have demonstrated that radiofrequency (RF) applications delivered to eliminate any ATP-induced dormant PV conduction have reduced the clinical recurrence of atrial fibrillation (AF) after initial PVI. 2, 3 However, the usefulness of ATP administration during a re-do procedure for recurrent atrial arrhythmias has not been elucidated. We present a case in which ATP was effective in identifying the dormant PV conduction responsible for a recurrent atrial tachyarrhythmia.
Case Report
A 61-year-old man with a history of drug-resistant paroxysmal AF had undergone extensive PVI. The left atrial diameter and left atrial ejection fraction were within normal limits. During the initial procedure, double circular mapping catheters (Lasso, Biosense Webster) were placed in the superior and inferior PVs, and the left-sided and right-sided ipsilateral PVs were circumferentially and extensively ablated, respectively, under fluoroscopic and electrophysiologic guidance. 4, 5 After isolating all the PVs, no reconnection between the left atrium (LA) and the PVs was observed during the administration of 40 mg (0.8 mg/kg) of ATP under an isoproterenol (ISP) infusion (2 μg/min). However, 4 weeks after the procedure, he began to suffer from recurrent atrial tachycardia (AT) (Figure 1) , which was sustained for several hours, and occurred 2-3 times per week.
In the re-do ablation session, the patient presented in sinus rhythm. All 4 PVs were isolated, and dissociated PV potentials were observed in the right superior PV (RSPV) (Figure 2A ). An ISP infusion (2 μg/min) could not induce any PV reconnections, and no AT could be provoked by programmed stimulation.
We then administered 40 mg of ATP to evaluate the existence of any dormant PV conduction. A transient LA-PV reconnection reproducibly appeared at the RSPV ( Figure 2B ). Rapid PV firing occurred spontaneously from the RSPV during the reconnection, which caused an AT with the same P-wave morphology as the clinical AT (Figures 3A,B) . We eliminated the RSPV-LA conduction with a single RF application while the reconnection was exposed (Figures 4B,C) . After the RF application, the RSPV-LA reconduction no longer appeared and after followup of 6 months, the patient has been free of any atrial arrhythmias without any antiarrhythmic drugs.
Discussion
Previous studies have identified the PVs as the source of triggers initiating and perpetuating AF. PVI is now an established therapy for curing AF. 6, 7 Arentz et al reported that adenosine induced transient conduction in 25% of PVs immediately after successful isolation. 1 In that study, the dose of the adenosine was 12-18 mg, and the adenosineinduced PV reactivation persisted for approximately 20s. Furthermore, it has been shown that additional RF applications after the PVI in order to eliminate any ATP-induced dormant PV conduction improved the clinical outcome of the initial PVI procedure. 2, 3 In those studies, the dose of the ATP was 20-30 mg and it was administered during intravenous ISP infusion. Although the reason the ATP was able to elucidate the dormant conduction was not sufficiently clarified, the following mechanism was suggested: adenosine activates the outward potassium current via purinergic A1-receptors. The resulting hyperpolarization of the cell membrane and shortening of the action potential/refractory period may facilitate electrotonic conduction. Given that the dormant conduction was eliminated by a single RF application in the present case, the induced AT was likely to have occurred because of electrical conduction of the PV firing to the LA through a conduction gap. Because the P waves of the clinical AT had the same morphology as those of the induced AT, the clinical AT may have been caused by a similar mechanism. The fact that no further frequent clinical AT has occurred since the re-do session strongly suggests that the dormant PV conduction was responsible for the occurrence of the clinical condition. Actually, we need to rule out a focal AT, a micro-or a macro-reentrant tachycardia, including the ablation site, as a critical lesion for maintaining those tachycardias; however, considering that the AT was only induced after rapid PV firing following the LA-PV re-connection, the aforementioned mechanism is more likely. The reason for the difference in the persistence of the clinical and induced ATs remains uncertain. Some neurohormonal conditions, such as increased sympathetic nervous activity, may have been associated with the long duration of the clinical AT.
Clinical Implications
These observations confirm the importance of dormant PV conduction as a cause of recurrent atrial arrhythmias following AF ablation. When no PV-LA conduction is observed during a re-do ablation session, evaluation of the existence of any dormant PV conduction using ATP may useful for clarifying the etiology and cure of a recurrent atrial arrhythmia, in addition to that done in the initial session during the acute phase. 
